代谢功能障碍相关脂肪变性肝病治疗的研究进展  

Research progress in the treatment of metabolic dysfunction-associated steatotic liver disease

作　　者：李福建 宋怀宇[1] 黄定贵[2] LI Fujian;SONG Huaiyu;HUANG Dinggui(Department of Gastroenterology,the People's Hospital of Guangxi Zhuang Autonomous Region(Guangxi Academy of Medical Sciences),Nanning 530021,China;Health Examination Center,the People's Hospital of Guangxi Zhuang Autonomous Region(Guangxi Academy of Medical Sciences),Nanning 530021,China)

机构地区：[1]广西壮族自治区人民医院(广西医学科学院)消化科,南宁530021 [2]广西壮族自治区人民医院(广西医学科学院)健康体检中心,南宁530021

出　　处：《中国临床新医学》2024年第3期351-354,共4页CHINESE JOURNAL OF NEW CLINICAL MEDICINE

基　　金：广西医疗卫生适宜技术开发与推广应用项目(编号:S2019080);广西卫生健康委员会自筹经费科研课题(编号:Z-A20230161)。

摘　　要：代谢功能障碍相关脂肪变性肝病(MASLD)是慢性肝病之一,严重危害人类健康。其发病机制复杂,目前尚无特效治疗药物。近年来的研究提出了更多的发病机制及对应的治疗方案。该文对代谢功能障碍相关脂肪变性肝病治疗的研究进展作一综述。Metabolic dysfunction-associated steatotic liver disease(MASLD)is one of the chronic liver diseases,which causes a serious hazard to human health.However,the pathogenesis mechanisms of MASLD are complex and no specific drugs are available to treat it at present.In recent years,studies have proposed more pathogenesis mechanisms and their corresponding therapeutic schemes.This paper reviews the research progress in the treatment of MASLD.

关 键 词：代谢功能障碍相关脂肪变性肝病 生活方式管理 药物治疗 手术治疗 

分 类 号：R575[医药卫生—消化系统]